Radiation oncology firm Elekta has received the CE Mark and clearance from the U.S. Food and Drug Administration (FDA) for new features for its Versa HD linear accelerator.
The upgrade includes automated breath-hold gating for breast and lung radiotherapy, called Active Breathing Coordinator. The feature works with Elekta's Response gating algorithm, helping patients pause their breathing at a particular tidal volume, according to Elekta.
Automated breath-hold gating allows clinicians to reduce tumor margins and perform treatments such as stereotactic body radiation therapy with image-guided radiation therapy in a standard treatment time slot, Elekta said.
